50 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 500% to $35.52. Scopus BioPharma’s filing showed registration for 500,000 share common stock offering. Scopus Biopharma shares gained around 8% on Wednesday after the company priced its IPO at $5.5 per share.
• MingZhu Logistics Holdings Ltd (NASDAQ: YGMZ) shares climbed 205% to $12.22 .
• Nxt-ID, Inc. (NASDAQ: NXTD) climbed 94.3% to $1.7950 after jumping around 90% on Wednesday.
• Oriental Culture Holding Ltd (NASDAQ: OCG) gained 90.8% to $11.64 as a potential post IPO volatility. Oriental Cultural, on Tuesday, priced its IPO at $4 per share.
• Wunong Net Technology Company Limited (NASDAQ: WNW) shares gained 80.1% to $117.22 after jumping 440% on Wednesday. The company, on Tuesday, priced its IPO at $5 per share.
• Vivos Therapeutics, Inc. (NASDAQ: VVOS) climbed 37.4% to $9.31. Vivos Therapeutics, earlier during the month, priced its IPO at $6 a share.
• Jupiter Wellness, Inc. (NASDAQ: JUPW) gained 36.1% to $7.20 after climbing 19% on Wednesday. Jupiter Wellness, recently reported the acquisition of SRM Entertainment, LTD from Vinco Ventures, Inc.
• Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 30% to $4.79 after the company issued regulatory update for IV Tramadol.
• Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) surged 30% to $4.2916.
• Upstart Holdings, Inc. (NASDAQ: UPST) gained 24% to $36.53. Upstart Holdings shares surged 47% on Wednesday after the company priced its IPO at $20 per share.
• Evolus, Inc. (NASDAQ: EOLS) rose 22.6% to $4.50 after the company issued an update on United States International Trade Commission (ITC) case.
• Marathon Patent Group, Inc.. (NASDAQ: MARA) gained 22.6% to $10.09 after surging 16% on Wednesday.
• PainReform Ltd. (NASDAQ: PRFX) jumped 20% to $5.20.
• Rite Aid Corporation (NYSE: RAD) climbed 18% to $20.18 after the company reported better-than-expected Q3 results and issued strong FY21 guidance .
• Bit Digital, Inc. (NASDAQ: BTBT) shares climbed 17.8% to $5.95 following an 18% decline on Wednesday. Bit Digital, earlier during the month, highlighted completion of acquisition of $13,902,742 worth of bitcoin miners with total hash rate of 1,003.5 Ph/s.
• TuanChe Limited (NASDAQ: TC) surged 17.8% to $5.03.
• MiMedx Group, Inc. (NASDAQ: MDXG) surged 16.4% to $9.11. MiMedx Group shares jumped 19% on Wednesday after Prescience Point Capital Management, a company shareholder, gave bullish commentary on the stock and issued a $31 price target.
• Cogent Biosciences, Inc. (NASDAQ: COGT) gained 16.3% to $12.65. SVB Leerink, on Wednesday, initiated coverage on Cogent Biosciences with an Outperform rating and a price target of $20.
• Canaan Inc. (NASDAQ: CAN) rose 16.1% to $4.41 after gaining around 7% on Wednesday.
• fuboTV Inc. (NASDAQ: FUBO) gained 15.8% to $34.41.
• Drive Shack Inc. (NASDAQ: DS) surged 14.8% to $3.25. Drive Shack is scheduled to reopen its Orlando venue on December 18th.
• Skillful Craftsman Education Technology Limited (NASDAQ: EDTK) rose 14.7% to $3.3211.
• Ondas Holdings Inc. (NASDAQ: ONDS) shares jumped 14.5% to $7.10.
• Enlivex Therapeutics Ltd. (NASDAQ: ENLV) rose 10.4% to $11.30. Enlivex, earlier during the month, reported issuance of new Chinese patent covering allocetra immunotherapy.
• 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 8.6% to $0.82. OrbiMed Israel BioFund GP Limited Partnership reported a 16% stake in 9 Meters Biopharma.
• Accenture plc (NYSE: ACN) rose 8.5% to $268.55 after the company reported upbeat Q1 results and issued strong Q2 sales forecast.
• Jabil Inc (NYSE: JBL) climbed 6.6% to $43.75 after the company posted upbeat Q1 results and issued strong Q2 earnings outlook.
• Lennar Corporation (NYSE: LEN) rose 6% to $78.77 following upbeat quarterly earnings.
• Roku, Inc. (NASDAQ: ROKU) rose 4.3% to $339.79. Roku is partnering with AT&T’s subscription video-on-demand streaming service HBO Max starting Thursday.

Check out these big penny stock gainers and losers

Losers

• Triterras Inc (NASDAQ: TRIT) shares dipped 36.5% to $8.39 after confirming it informed a statutory demand for payment was made to Antanium Resources in Singapore. Triterras said in a regulatory filing it was informed that a statutory demand for payment from Antainium Resources (formerly known as Rhodium Resources) was filed by a creditor of Rhodium on Dec. 1.
• BioCardia Inc (NASDAQ: BCDA) fell 25.5% to $4.3189. BioCardia disclosed positive DSMB review and recommendation to continue Phase III pivotal CardiAMP heart failure study as designed. BioCardia recently reported a 1.789 million share registered direct offering priced at $4.75 per share.
• CooTek (Cayman) Inc. (NYSE: CTK) shares dipped 22.5% to $3.1473. CooTek, on Wednesday, reported a mixed securities shelf offering.
• Dragon Victory International Limited (NASDAQ: LYL) dropped 19.5% to $2.2292.
• Mediaco Holding Inc (NASDAQ: MDIA) fell 19.2% to $2.91 after climbing around 35% on Wednesday.
• SCYNEXIS, Inc. (NASDAQ: SCYX) fell 18.3% to $5.99 after the company announced the launch of $50 million common stock and warrant offering.
• Uxin Limited (NASDAQ: UXIN) fell 17.3% to $1.1582 after reporting Q2 results.
• Standard Motor Products, Inc. (NYSE: SMP) shares dropped 15.8% to $45.39.
• Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) dipped 15.7% to $3.52 as the company issued regulatory update on Zygel in Fragile X syndrome.
• Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) dropped 14% to $8.90. FatBoy Capital, on Wednesday, disclosed a 6.9% active stake in the company.
• Surface Oncology, Inc. (NASDAQ: SURF) fell 13.7% to $8.60. Surface Oncology announced an agreement for GlaxoSmithKline to exclusively license worldwide development and commercial rights to its preclinical program SRF813, an inhibitory protein expressed on natural killer cells and T cells, for an $85-million upfront payment.
• Herman Miller, Inc. (NASDAQ: MLHR) dropped 13.2% to $35.20 after reporting Q2 results.
• R. R. Donnelley & Sons Company (NASDAQ: RRD) fell 12.8% to $1.8220 after climbing around 19% on Wednesday. R.R. Donnelley, last week, reported a vaccination distribution toolkit to support marketing and operations for pending COVID-19 vaccine.
• Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) dropped 12.6% to $40.25 as the company reported pricing of public offering of common stock.
• Atossa Therapeutics, Inc. (NASDAQ: ATOS) shares fell 9.8% to $0.8659 after gaining around 10% on Wednesday. Atossa Therapeutics, last week, priced a $20 million underwritten public offering.
• Qutoutiao Inc. (NASDAQ: QTT) fell 9.7% to $2.2582 following Q3 results.
• CureVac N.V. (NASDAQ: CVAC) fell 9% to $105.75. CureVac recently announced the commencement of its global pivotal Phase2b/3 trial for its Covid-19 vaccine candidate CVnCoV.
• Apollo Endosurgery, Inc. (NASDAQ: APEN) shares fell 7.8% to $3.66. Apollo Endosurgery, on Wednesday, announced it received FDA clearance for the X-Tack Endoscopic HeliX Tacking System.
• Heat Biologics, Inc. (NASDAQ: HTBX) fell 6.6% to $5.51. Heat Biologics shares climbed around 10% on Wednesday after the company announced completion of ZVX-60 vaccine cell line for COVID-19.
• Allied Esports Entertainment Inc. (NASDAQ: AESE) fell 5.3% to $1.5150. Allied Esports, on Wednesday, launches 24-hour cross-channel content strategy on Twitch.
• Aethlon Medical, Inc. (NASDAQ: AEMD) fell 5.1% to $2.1450. Aethlon Medical shares jumped over 40% on Wednesday after the company treated the first patient in its first-in-human Early Feasibility Study of the HEMOPURIFIER.